Canada's Canopy Growth Q1 revenue slightly misses estimates
Canada's Canopy Growth Q1 revenue slightly misses estimates
Overview
Canada cannabis producer's fiscal Q1 net revenue rose 13% yr/yr, slightly missed analyst expectations
Adjusted EBITDA loss for fiscal Q1 narrowed by 59% yr/yr, driven by revenue growth and cost savings
Adjusted gross margin improved to 31% from 25% yr/yr
Outlook
Company anticipates further financial improvements, especially in H2 FY2027, as MTL Cannabis integration completes
Canopy Growth expects growth in each end market driven by clear strategies and increased high-quality flower supply
Company sees expanded revenue opportunities and meaningful synergies from MTL Cannabis acquisition
Result Drivers
MTL CANNABIS ACQUISITION - Co said acquisition led to increased supply of high-quality flower and expanded revenue opportunities, supporting growth in Canada medical and adult-use cannabis
SEGMENT SALES GROWTH - Co reported net revenue growth in Canada medical cannabis (22%), Canada adult-use cannabis (10%), international markets cannabis (10%), and Storz & Bickel (6%)
COST RATIONALIZATION - Storz & Bickel gross margin rose due to cost rationalization and recovery of certain U.S. tariffs
Company press release: ID:nBw8cfx25a
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q1 Net Revenue | Slight Miss* | C$81.20 mln | C$81.63 mln (5 Analysts) |
Q1 Adjusted EBITDA |
| -C$3.20 mln |
|
Q1 Gross Margin |
| 27.00% |
|
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"
Wall Street's median 12-month price target for Canopy Growth Corporation is C$1.60, about 20.3% above its August 6 closing price of C$1.33
Reuters Recommended Reads
Aug 5 - Aurora Cannabis Q1 revenue falls 9% on Canadian reimbursement cuts
Aug 6 - Canada's Cronos Group Q2 revenue beats estimates on higher cannabis flower sales
Aug 6 - Canada's TerrAscend Q2 revenue beats estimates on retail strength
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Canopy Growth
See all newsBrief: Canopy Growth Secures Renewed EU Gmp Certification At Kincardine As European Medical Cannabis Business Grows
Canada's Canopy Growth Q1 revenue slightly misses estimates
Canada's Canopy Growth Q4 revenue rises
Corrected: BRIEF-Canopy Growth Corp Q4 Revenue CAD 71.24 Million Vs. IBES Estimate CAD 74.4 Million
Brief: Canopy Growth Relaunches Tweed Brand In Germany With New Mtl Cannabis Strain Lineup, Marking First International Release Following Acquisition